Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Nephrology 4, 348–349 (1 July 2008) | doi:10.1038/ncpneph0836
Benefit from blood-pressure-lowering drugs is linked to urinary albumin level
Abstract
Boersma C et al. (2008) Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events. Br J Clin Pharmacol 65: 723–732 In an observational analysis of Dutch adults who participated in the community-based PREVEND trial, Boersma et al. have shown that hypertensive people with elevated urinary albumin levels receive a greater benefit from blood-pressure-lowering drugs, especially those that interfere with the renin–angiotensin system, than do individuals with normal urinary albumin levels.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
